The Japanese Ministry of Health, Labour, and Welfare (MHLW) has granted approval to Sarepta Therapeutics’ gene therapy Elevidys (delandistrogene moxeparvovec) for treating Duchenne muscular ...

Matt Bellina Regained Function After Receiving NurOwn via the Right to Try Law He Fought to Pass and Now He is Fighting for All Americans with ALS to Get the Same Chance He Did BREMERTON, WA / ACCESS ...

The company reported lower-than-expected revenue for its gene therapy product, Elevidys, in the first quarter of 2025, which amounted to $375 million, falling short of the $444 million forecasted ...

Cellares, in collaboration with Mitsui Fudosan, will establish Japan’s first next-gen commercial production site for CAR-T cell therapies. The facility is under construction in Kashiwa City.

Japan CAR‐T cell therapies market Japan CAR-T Cell Therapies Market grows at 16.3% CAGR, driven by rising cancer cases, R&D, regulatory sup Tuesday, 02 January 2024 12:17 GMT عربي ...

Japan's regenerative medicine cold chain logistics market thrives on aging demographics, stringent regulations, and advanced tech, with global leaders like DHL, World Courier, and UPS driving ...

YOKOTA AIR BASE, Japan — A company that provides hard-to-find English speech therapy services across Japan plans to open a clinic next month near this airlift hub in western Tokyo. ShisaCare’s ...